Risperidone의 임상적 안전성

• 영문명: Clinical Safety of Risperidone
• 발행기관: 대한신경정신의학회
• 저자명: 백운수 강병조 김승팔
• 간행물 정보: 『신경정신의학』제33권 제2호, 453~461쪽, 전체 9쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 1994.03.30

영문 초록

This study was designed to investigate the clinical safety of risperidone. The subjects consisted of 19 patients diagnosed as chronic schizophrenia with DSM-III-R, who had been admitted to the Taegu Catholic mental hospital from April 26, 1991 to December 19, 1991. After a wash-out period of 7 days, they were treated with risperidone for a period of 16 weeks unders single open condition. The mean dosage of risperidone administered to patients were 11.89土 4.59 mg per day. Blood pressure, heart rate, body weight, hematology, biochemistry, ECG were assessed : extrapyramidal symptoms were assessed by means of ESRS : other side effects were evaluated by UKU side effect rating scale. The results were as follows : 1) Among vital signs, changes of standing heart rate(P

목차

서 론

대상 및 방법

결 과

결 론

참고문헌

키워드

Chronic schizophrenia Risperidone Clinical safety

참고문헌